Site-specific phosphorylation of tau impacts mitochondrial biology and response to stressors.

Autor: Isei MO; University of Rochester, Department of Anesthesiology & Perioperative Medicine, Rochester, New York, USA., Girardi PA; University of Rochester, Department of Anesthesiology & Perioperative Medicine, Rochester, New York, USA., Rodwell-Bullock J; University of Rochester, Department of Anesthesiology & Perioperative Medicine, Rochester, New York, USA., Nehrke K; University of Rochester, Department of Medicine, Nephrology Division, Rochester, New York, USA., Johnson GV; University of Rochester, Department of Anesthesiology & Perioperative Medicine, Rochester, New York, USA.
Jazyk: angličtina
Zdroj: BioRxiv : the preprint server for biology [bioRxiv] 2023 Feb 19. Date of Electronic Publication: 2023 Feb 19.
DOI: 10.1101/2023.02.19.529131
Abstrakt: Phosphorylation of tau at sites associated with Alzheimer's disease (AD) likely plays a role in the disease progression. Mitochondrial impairment, correlating with increased presence of phosphorylated tau, has been identified as a contributing factor to neurodegenerative processes in AD. However, how tau phosphorylated at specific sites impacts mitochondrial function has not been fully defined. We examined how AD-relevant phosphomimetics of tau impact selected aspects of mitochondrial biology. To mimic phosphorylation at AD-associated sites, the Ser/Thr sites in wild-type GFP tagged-tau (T4) were converted to glutamic acid (E) to make pseudophosphorylated GFP tagged-Ser-396/404 (2EC) and GFP tagged-Thr-231/Ser-235 (2EM) constructs. These constructs were expressed in neuronal HT22 cells and their impact on specific mitochondrial functions and responses to stressors were measured. Phosphomimetic tau altered mitochondrial distribution. Specifically, mitochondria accumulated in the soma of cells expressing either 2EC or 2EM, and neurite-like extensions in 2EC cells were shorter. Additionally, ATP levels were reduced in both 2EC and 2EM expressing cells, and ROS production increased in 2EC cells during oxidation of succinate when compared to T4 expressing cells. Thapsigargin reduced mitochondrial membrane potential (Ψ m ) and increased ROS production in both 2EC and 2EM cells relative to T4 cells, with no significant difference in the effects of rotenone. These results show that tau phosphorylation at specific AD-relevant epitopes negatively affects mitochondria, with the extent of dysfunction and stress response varying according to the sites of phosphorylation. Altogether, these findings extend our understanding of potential mechanisms whereby phosphorylated tau promotes mitochondria dysfunction in tauopathies, including AD.
Funding Information: R01 AG067617.
Databáze: MEDLINE
Externí odkaz: